No connection

Search Results

CLLS vs SIGA

CLLS
Cellectis S.A.
BEARISH
Price
$3.36
Market Cap
$338.0M
Sector
Healthcare
AI Confidence
45%
SIGA
SIGA Technologies, Inc.
BEARISH
Price
$4.76
Market Cap
$341.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
CLLS
--
SIGA
14.88
Forward P/E
CLLS
-5.42
SIGA
3.24
P/B Ratio
CLLS
3.2
SIGA
1.71
P/S Ratio
CLLS
4.25
SIGA
3.61
EV/EBITDA
CLLS
-5.98
SIGA
7.7

Profitability

Gross Margin
CLLS
100.0%
SIGA
47.49%
Operating Margin
CLLS
-142.14%
SIGA
-250.38%
Profit Margin
CLLS
-84.92%
SIGA
24.62%
ROE
CLLS
-65.33%
SIGA
11.23%
ROA
CLLS
-5.84%
SIGA
6.39%

Growth

Revenue Growth
CLLS
-19.5%
SIGA
-95.3%
Earnings Growth
CLLS
--
SIGA
--

Financial Health

Debt/Equity
CLLS
1.14
SIGA
0.0
Current Ratio
CLLS
1.62
SIGA
11.83
Quick Ratio
CLLS
1.59
SIGA
8.79

Dividends

Dividend Yield
CLLS
--
SIGA
--
Payout Ratio
CLLS
0.0%
SIGA
0.0%

AI Verdict

CLLS BEARISH

CLLS shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.

Strengths
Company has established market presence
Risks
Low profit margin of -84.9%
Weak financial trend (Piotroski F-Score: 1/9)
Declining revenue (-19.5%)
SIGA BEARISH

SIGA presents a stark contrast between a pristine balance sheet and a collapsing operational core, evidenced by a Piotroski F-Score of 4/9 (Stable). While the company maintains zero debt and an exceptional current ratio of 11.83, the YoY revenue decline of -95.30% and an operating margin of -250.38% indicate a severe crisis in business continuity. The current price of $4.76 trades at a premium to both the Graham Number ($4.47) and the Intrinsic Value ($2.24), suggesting the stock is overvalued relative to its fundamentals. Technical trends are fully bearish, and the earnings track record shows a consistent failure to meet analyst expectations.

Strengths
Zero debt (Debt/Equity: 0.00)
Extremely high liquidity (Current Ratio: 11.83)
Strong gross margins (47.49%)
Risks
Catastrophic revenue collapse (-95.30% YoY)
Severe operating losses (Operating Margin: -250.38%)
Consistent earnings misses (0/4 beats in last 4 quarters)

Compare Another Pair

CLLS vs SIGA: Head-to-Head Comparison

This page compares Cellectis S.A. (CLLS) and SIGA Technologies, Inc. (SIGA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile